Press Releases

Year

May 15, 2018

Surface Oncology to Present at 2018 UBS Global Healthcare Conference

April 23, 2018

Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

April 18, 2018

Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

March 20, 2018

Surface Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of SRF231

February 22, 2018

Surface Oncology Expands Board Of Directors

February 12, 2018

Surface Oncology Promotes Jeff Goater to Chief Executive Officer